Robin R. Frey

2.1k total citations
14 papers, 594 citations indexed

About

Robin R. Frey is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Robin R. Frey has authored 14 papers receiving a total of 594 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Oncology and 4 papers in Organic Chemistry. Recurrent topics in Robin R. Frey's work include Histone Deacetylase Inhibitors Research (6 papers), Protein Degradation and Inhibitors (6 papers) and Peptidase Inhibition and Analysis (3 papers). Robin R. Frey is often cited by papers focused on Histone Deacetylase Inhibitors Research (6 papers), Protein Degradation and Inhibitors (6 papers) and Peptidase Inhibition and Analysis (3 papers). Robin R. Frey collaborates with scholars based in United States and United Kingdom. Robin R. Frey's co-authors include Steven K. Davidsen, Keith B. Glaser, Michael L. Curtin, Lori J. Pease, Patrick A. Marcotte, Robert B. Garland, Junling Li, Michael R. Michaelides, Jennifer J. Bouska and H. Robin Heyman and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Robin R. Frey

14 papers receiving 571 citations

Peers

Robin R. Frey
Thomas J. Lanza United States
Michael R. Michaelides United States
H. Robin Heyman United States
James E. Sheppeck United States
Carol K. Wada United States
Luciana Auzzas Italy
Eugene L. Piatnitski Chekler United States
J. Adam Willardsen United States
Herwig Pongratz Germany
Vijayaratnam Santhakumar Canada
Thomas J. Lanza United States
Robin R. Frey
Citations per year, relative to Robin R. Frey Robin R. Frey (= 1×) peers Thomas J. Lanza

Countries citing papers authored by Robin R. Frey

Since Specialization
Citations

This map shows the geographic impact of Robin R. Frey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin R. Frey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin R. Frey more than expected).

Fields of papers citing papers by Robin R. Frey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin R. Frey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin R. Frey. The network helps show where Robin R. Frey may publish in the future.

Co-authorship network of co-authors of Robin R. Frey

This figure shows the co-authorship network connecting the top 25 collaborators of Robin R. Frey. A scholar is included among the top collaborators of Robin R. Frey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robin R. Frey. Robin R. Frey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Curtin, Michael L., Robin R. Frey, H. Robin Heyman, et al.. (2012). Thienopyridine ureas as dual inhibitors of the VEGF and Aurora kinase families. Bioorganic & Medicinal Chemistry Letters. 22(9). 3208–3212. 19 indexed citations
2.
Curtin, Michael L., H. Robin Heyman, Robin R. Frey, et al.. (2012). Pyrazole diaminopyrimidines as dual inhibitors of KDR and Aurora B kinases. Bioorganic & Medicinal Chemistry Letters. 22(14). 4750–4755. 12 indexed citations
3.
Curtin, Michael L., Robin R. Frey, Niru B. Soni, et al.. (2011). Abstract C202: Discovery and initial characterization of the clinical compound ABT-348, a potent inhibitor of the VEGF, PDGF, and Aurora kinase families.. Molecular Cancer Therapeutics. 10(11_Supplement). C202–C202. 1 indexed citations
4.
Frey, Robin R., Michael L. Curtin, Daniel H. Albert, et al.. (2008). 7-Aminopyrazolo[1,5-a]pyrimidines as Potent Multitargeted Receptor Tyrosine Kinase Inhibitors. Journal of Medicinal Chemistry. 51(13). 3777–3787. 42 indexed citations
5.
Heyman, H. Robin, Robin R. Frey, Peter F. Bousquet, et al.. (2006). Thienopyridine urea inhibitors of KDR kinase. Bioorganic & Medicinal Chemistry Letters. 17(5). 1246–1249. 33 indexed citations
6.
Matulenko, Mark A., Ernest S. Paight, Robin R. Frey, et al.. (2006). 4-Amino-5-aryl-6-arylethynylpyrimidines: Structure–activity relationships of non-nucleoside adenosine kinase inhibitors. Bioorganic & Medicinal Chemistry. 15(4). 1586–1605. 25 indexed citations
7.
Glaser, Keith B., Lori J. Pease, Michael J. Staver, et al.. (2004). Differential protein acetylation induced by novel histone deacetylase inhibitors. Biochemical and Biophysical Research Communications. 325(3). 683–690. 51 indexed citations
8.
Li, Junling, Michael J. Staver, Michael L. Curtin, et al.. (2004). Expression and functional characterization of recombinant human HDAC1 and HDAC3. Life Sciences. 74(22). 2693–2705. 37 indexed citations
9.
Curtin, Michael L., Robin R. Frey, H. Robin Heyman, et al.. (2004). Isoindolinone ureas: a novel class of KDR kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(17). 4505–4509. 26 indexed citations
10.
Vasudevan, Anil, Zhiqin Ji, Robin R. Frey, et al.. (2003). Heterocyclic ketones as inhibitors of histone deacetylase. Bioorganic & Medicinal Chemistry Letters. 13(22). 3909–3913. 33 indexed citations
11.
Wada, Carol K., Robin R. Frey, Zhiqin Ji, et al.. (2003). α-Keto amides as inhibitors of histone deacetylase. Bioorganic & Medicinal Chemistry Letters. 13(19). 3331–3335. 67 indexed citations
12.
Curtin, Michael L., Robert B. Garland, H. Robin Heyman, et al.. (2002). Succinimide hydroxamic acids as potent inhibitors of histone deacetylase (HDAC). Bioorganic & Medicinal Chemistry Letters. 12(20). 2919–2923. 97 indexed citations
13.
Frey, Robin R., Carol K. Wada, Robert B. Garland, et al.. (2002). Trifluoromethyl ketones as inhibitors of histone deacetylase. Bioorganic & Medicinal Chemistry Letters. 12(23). 3443–3447. 116 indexed citations
14.
Reichelt, Andreas, et al.. (2002). Design, Synthesis, and Evaluation of Matrix Metalloprotease Inhibitors Bearing Cyclopropane-Derived Peptidomimetics as P1‘ and P2‘ Replacements. The Journal of Organic Chemistry. 67(12). 4062–4075. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas J. Lanza Breakdown of academic impact, for papers by Michael R. Michaelides Breakdown of academic impact, for papers by H. Robin Heyman Breakdown of academic impact, for papers by James E. Sheppeck Breakdown of academic impact, for papers by Carol K. Wada Breakdown of academic impact, for papers by Luciana Auzzas Breakdown of academic impact, for papers by Eugene L. Piatnitski Chekler Breakdown of academic impact, for papers by J. Adam Willardsen Breakdown of academic impact, for papers by Herwig Pongratz Breakdown of academic impact, for papers by Vijayaratnam Santhakumar
Rankless by CCL
2026